Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171314
Status:
COMPLETED
Last Update Posted:
2012-04-11
First Post:
2005-09-12
Brief Title:
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis